Business

Roivant Sciences has acquired global rights to Patara Pharma's PA101 cromolyn sodium inhalation solution for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), the company said. The inhalation solution, which will now be called RVT-1601, is delivered via the PARI eFlow nebulizer. In 2016, Patara announced positive results from a … [Read more...] about Roivant acquires global rights to Patara’s inhaled cromolyn sodium

United Therapeutics will pay MannKind Corporation $45 million up front and up to $50 million in milestone payments, plus potential double-digit royalties for a worldwide exclusive licensing and collaboration agreement for development and commercialization of a treprostinil DPI for the treatment of pulmonary arterial hypertension (PAH), the companies said. In June … [Read more...] about United Therapeutics and MannKind partner for development of treprostinil DPI for PAH

Glenmark Pharmaceuticals said that it has acquired an exclusive license to market a generic tiotropium bromide dry powder inhaler in Western Europe. The DPI, a generic version of Boehringer Ingelheim's Spiriva Handihaler for the treatment of COPD, is the second inhaler Glenmark has licensed for the European market. In 2015, Glenmark announced that it had entered … [Read more...] about Glenmark licenses tiotropium DPI in Western Europe

Product Quest manufacturing, which recently announced a recall of CVS Health 12 Hour Sinus Relief Nasal Mist oxymetazoline nasal spray due to contamination with Pseudomonas aeruginosa, has now recalled all of the nasal products it manufactured at its Florida facility "out of an abundance of caution." The company provided a 63-page document listing over1,000 … [Read more...] about Product Quest recalls nasal sprays sold at major US retailers

Adherium recently received OTC clearance for its Hailie inhaler monitoring platform in the US, and the company says that it has now launched direct-to-consumer sales through a web site. Hailie includes an inhaler sensor and a smartphone app that allows patients to monitor their own inhaler use, and a new web portal will provide health care providers with access to … [Read more...] about Adherium launches Hailie inhaler sensor in US

Haisco Pharmaceutical Group has acquired Chinese rights to products developed by Pneuma Respiratory in a deal that included a $10 million equity investment in Pneuma, the company said. In addition to the equity investment, Haisco will fund Chinese regulatory filings. In July 2018, Pneuma Respiratory said that it had completed a series A fundraising round that … [Read more...] about Haisco gets rights to distribute Pneuma Respiratory products in China

Perrigo has licensed the US rights to an over-the-counter version of Merck's Nasonex mometasone furoate nasal spray, the company said. The company did not disclose the financial terms of the deal, which give Perrigo the right to seek regulatory approval, market, sell, and distribute the product. Nasonex, which was approved by the FDA in 1997, is currently … [Read more...] about Perrigo gets US rights to OTC version of Nasonex nasal spray

United Therapeutics has announced a settlement agreement with Watson Laboratories that includes a license for Watson to manufacture and sell a generic version of Tyvaso treprostinil inhalation solution as of January 1, 2026. Watson is currently a subsidiary of Teva. The settlement resolves litigation that had been ongoing since Watson filed an ANDA for the … [Read more...] about United Therapeutics grants Watson license for generic version of Tyvaso inhalation solution